Share. Connect. Create. Grow. · Socialiya
Autogene Cevumeran & The Future of Personalized Cancer Vaccines

Data from a phase 1 trial suggest that durable, vaccine-induced T-cell memory may be achievable even...

HEALTH NEWS April 22, 2026

Autogene Cevumeran & The Future of Personalized Cancer Vaccines

Data from a phase 1 trial suggest that durable, vaccine-induced T-cell memory may be achievable even in pancreatic ductal adenocarcinoma.

14 views 0 likes 0 comments
Share:
Data from a phase 1 trial suggest that durable, vaccine-induced T-cell memory may be achievable even in pancreatic ductal adenocarcinoma.

Author: CancerNetwork

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya